Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) PT at $506.70
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong […]
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong […]
